The reliability of radiofrequency ablation for the treatment of essential hypertension requires further clinical studies. Renal sympathetic nerve radiofrequency ablation is a non-pharmacological treatment for hypertension that involves destroying nerves within the walls of the renal arteries through radiofrequency or ultrasound energy, thereby reducing sympathetic efferent and sensory afferent signals in and out of the kidneys and further controlling blood pressure. Although some studies have shown that renal sympathetic nerve radiofrequency ablation is effective in controlling blood pressure, and the effect of lowering blood pressure after renal sympathetic nerve radiofrequency ablation for refractory hypertension can be sustained for up to 36 months when compared with drug therapy. However, according to the Chinese Guidelines for the Prevention and Treatment of Hypertension (2018 Revision ). Evidence on the efficacy and safety of denervation in the treatment of refractory hypertension is still insufficient, so the method is still in the clinical research stage and is not suitable for widespread clinical promotion. When elevated blood pressure is detected, it is necessary to go to the hospital in time, and the choice of treatment plan should follow the advice of professional doctors.